The present disclosure relates generally to tampon pledgets. More particularly, the present disclosure relates to tampon pledgets that exhibit increased bypass leakage protection.
Both in-vivo and in-vitro testing has shown that current tampon pledgets do not protect well against bypass leakage. In-vivo testing shows that the typical woman places the tampon pledget too deep into the vaginal canal and is not optimally placed to absorb fluid. In-vitro testing confirms that tampon pledget expansion is not optimal. With both of these insights, it is known that there is a propensity for the tampon pledgets to leak prematurely, i.e., bypass leakage.
There have been many attempts in the prior art to address bypass leakage. Examples include providing a tampon pledget with various pre-expanded, compressed shapes designed to conform to a user's anatomy upon insertion into the vagina. One particular drawback with the tampon pledget having a pre-expanded shape is that it may be difficult to house the pre-shaped pledget in a typical cylindrical applicator barrel due to its shape. Also, once housed in the applicator, the tampon pledget having the pre-expanded shape may exert additional forces on the walls of the applicator barrel due to its shape, which in turn could cause excess friction during expulsion, requiring additional force to expel the tampon pledget from the applicator. The required additional force could make use of the applicator difficult, and in some cases actually cause deformation of the applicator, making its use extremely difficult.
Therefore, there remains a need in the tampon art for a tampon pledget that mitigates or all together prevents bypass leakage, while also avoiding the drawbacks associated with the prior art. The present disclosure meets this need.
The present disclosure provides a tampon pledget that exhibits increased bypass leakage prevention.
The present disclosure also provides such a tampon pledget that has increased absorption potential at a base of the pledget.
The present disclosure further provides such a tampon pledget that has increased expansion potential at the base of the pledget.
The present disclosure still further provides such a tampon pledget where the desired pledget geometry occurs post-expansion.
The present disclosure yet further provides such a tampon pledget with varying fiber weight distribution across the length and/or width of the pledget.
The present disclosure also provides a method for assembling a tampon pledget that exhibits increased bypass leakage prevention.
These and other advantages and benefits of the present disclosure are provided by a tampon pledget that includes one or more enhanced features that result in the pledget exhibiting increased bypass leakage prevention. These enhanced features may include, but are not limited to, geometry, absorption, or any combinations thereof. The present disclosure also provides one or more methods for constructing a tampon pledget having increased bypass leakage protection.
The present disclosure provides a unique tampon pledget designed for various tampon sorts with one or more enhanced features including, but not limited to, increased absorption potential at the base of the pledget, increased expansion potential at the base of the pledget, and any combinations thereof. These enhanced features are achieved by constructing the tampon pledget with certain pad lay-up ratios, fiber weight distribution ratios, and any combinations thereof. As a result of these one or more enhanced features, a tampon pledget having increased bypass leakage protection results. Additionally, the enhanced features do not compromise the desired pledget geometry, or its pre-expansion ability. Therefore, applicator modifications are not required to house the tampon pledget of the present disclosure.
The present disclosure provides a unique tampon pledget designed for various tampon sorts with one or more enhanced features including, but not limited to, increased absorption potential at the base of the pledget, increased expansion potential at the base of the pledget, and any combinations thereof. These enhanced features are achieved by constructing the tampon pledget with certain pad lay-up ratios, fiber weight distribution ratios, and any combinations thereof. As a result of these one or more enhanced features, a tampon pledget having increased bypass leakage protection results. Additionally, the enhanced features do not compromise the desired pledget geometry, or its pre-expansion ability. Therefore, applicator modifications are not required to house the tampon pledget of the present disclosure.
to
It has been unexpectedly found that by providing one or more bottom pads 12 with one or more top pads 14 in certain pad lay-up ratios, and based on their respective areas, various desirable tampon pledget configurations can be achieved that provide enhanced bypass leakage protection. Area is defined herein as length times width (without depth as a factor). The pad lay-up ratio is defined as the ratio of the area of one or more bottom pads 12 to the area of one or more top pads 14, with the area of the one or more pads calculated in a single plane. Therefore, while stacking of multiple pads may be done, it does not increase the calculated area of the one or more pads.
Again referring to
In one embodiment, the one or more top pads 14 each have a length dimension 15 between about 2 inches and about 6 inches. In another embodiment, the one or more top pads 14 each have a length between about 3.5 inches and about 5.0 inches. In yet another embodiment, the one or more top pads 14 each has a length about 4 inches.
In one embodiment, the one or more top pads 14 each have a width dimension 16 between about 1 inches and about 4 inches. In another embodiment, the one or more top pads 14 each have a width between about 1.5 inches and about 3 inches. In yet another embodiment, the one or more top pads 14 each has a width about 2 inches.
In one embodiment, the one or more bottom pads 12 each have a length dimension 17 between about 1 inch and about 4 inches. In another embodiment, the one or more bottom pads 12 each have a length between about 2 inches and about 3 inches. In yet another embodiment, the one or more bottom pads 12 each have a length about 2.5 inches.
In one embodiment, the one or more bottom pads 12 each have a width dimension 18 between about 1 inch and about 4 inches. In another embodiment, the one or more bottom pads 12 each have a width between about 1.5 inches and about 3 inches. In yet another embodiment, the one or more bottom pads 12 each have a width about 2 inches.
In one embodiment of the present disclosure, the pad lay-up ratio is between about 1:1.2 to about 1:2.25. In another embodiment of the present invention, the pad lay-up ratio is about 1:1.6.
Another important aspect of the present disclosure is the fiber weight distribution ratio between the one or more bottom pads 12 and the one or more top pads 14. The fiber weight distribution ratio is defined as the ratio of the fiber weight distribution of the one or more bottom pads 12 to the fiber weight distribution of the one or more top pads 14.
In one embodiment according to the present disclosure, the fiber weight distribution ratio is between about 0.5:1 to about 2:1. In another embodiment according to the present disclosure, the fiber weight distribution ratio is between about 0.75:1 to about 1.5:1. In yet another embodiment according to the present disclosure, the fiber weight distribution ratio is about 1:1.
Suitable materials for use in forming the one or more bottom pads and/or the one or more top pads include, but are not limited to, cellulosic, rayon, cotton, pulp, superabsorbent, absorbent foam, and any combinations thereof.
The tampon pledget may include a liquid permeable coverstock or overwrap material, if desired. Suitable coverstock materials may include, but are not limited to, rayon, cotton, bicomponent fiber, or other suitable natural or synthetic fibers known in the art. Rayon, polyethylene, polypropylene and blends of these are particularly suited for use as a coverstock material.
The following examples demonstrate various embodiments according to the present disclosure. These examples are not intended to limit the scope of the present disclosure.
The pledget shape after exposure to moisture can vary according to the ratios set forth above in accordance with the present disclosure.
A tampon pledget 20 with a pad lay-up ratio of about 1:1.2 and fiber distribution ratio of about 0.75:1 may be constructed. Referring to
A tampon pledget 30 with a pad lay-up ratio of about 1:2.25 and fiber distribution ratio of about 1.5:1 may be constructed. Referring to
A tampon pledget 40 with a pad lay-up ratio of about 1:1.6 and fiber distribution ratio of about 1:1 may be constructed. Referring to
Several commercial tampon pledgets were purchased from retail stores to be used as comparative examples used to compare with tampon pledgets of this present disclosure. Comparative Example 4 tampons or tampon pledgets are Tampax Original (Super) tampons (available from Procter & Gamble); Comparative Example 5 tampons are Tampax Pearl (Super) Unscented tampons (available from Procter & Gamble); and Comparative Example 6 tampons are Kotex Security Super tampons (available from Kimberly Clark).
Referring to
To form the tampon pledgets of the above Examples, individual pads 110, 120 were arranged in a crosspad configuration according to the present disclosure invention and carefully weighed 130. Using a Hauni machine, the crosspad tampon pledget 130 was delivered and folded 140, using an appropriately sized (about 0.25″) fluted ram, into a cylindrical shaped transfer tube to form a cylindrical tampon pledget 150. The pledget was then transferred again using another ram into a warmed oven tube (inside diameter about 0.5″, temperature about 220° F.) and then conveyed by a pre-heated IR conveyor oven (Infrared Heating Technologies, LLC) 160. This heated, compressed cylindrical tampon pledget was then transferred into a slightly larger diameter stringer tube 170. In this tube, a needle was pierced through to permit a Nalan-coated string to be added and tied 180. Following the addition of string, the tampon pledget was added to a standard Gentle Glide™ plastic applicator 190. The petals on the applicator were then heated to about 190° F. and shaped, to “close” them 200. These finished tampon pledgets were stored for at least one day. Then testing, as outlined above, was performed.
Syngyna absorbency was evaluated according to the usual FDA mandated testing procedure, as outlined in the Federal Register, Part 801, 801.430. The Syngyna absorbency, measured for 20 such tampon pledgets, was 10.93+/−0.29 grams, consistent with a super absorbency tampon pledget.
A modified syngyna absorbency test, known as the positive displacement test, was performed. In this modification of the usual FDA procedure, instead of circulating the 27° C. water continuously inside the tube around the condom that encases the tampon pledget, the water was directed to a burette, which was located three inches higher than the top of the syngyna tube. The water level in this burette was adjusted to the zero level at the start of the syngyna experiment. Then, as the tampon pledget expanded to form a shape similar to the teardrop shape of
The purpose of this test was to see how rapidly the volume of the tampon pledget expanded during a syngyna absorbency experiment and to compare these results with those for comparable commercial tampon pledgets set forth in Comparative Examples 4 through 6.
Table 1 below provides these results. Twenty tampon pledgets for each of these examples were tested using the procedure outlined above. Since tampon pledget weights vary slightly from manufacturer to manufacturer, Table 1 reports normalized slopes; that is, the rate of volumetric increase vs. time was divided by the average pledget weights, to report the rates of increase in an even-handed manner. As the Table shows, tampon pledgets of the present disclosure exhibit a rate increase that is statistically significantly higher than existing commercial offerings. Notably, the average positive displacement rate is greater than 0.145. Preferably, the average displacement rate is greater than about 0.2.
The tampon pledgets according to the present disclosure, as exemplified by Example 7 in Table 1, have the majority of the absorption potential near the bottom of the tampon pledget. As a result of arranging the absorbent material of each tampon pledget in such a manner it promotes an expansion of the pledget that reduces bypass leakage.
The positive displacement in vitro test suggests that tampon pledgets of the present disclosure expand more rapidly than tampon pledgets made by alternative means. Moreover, the observed shapes that these tampon pledgets take during expansion (see Figures), owing to the modified weight and area distributions together with in vivo results suggests that tampon pledgets of the present disclosure should be more suitable “plugs” and thus provide more effective bypass leakage prevention.
While the present disclosure has been described with reference to one or more exemplary embodiments, it will be understood by those skilled in the art that various changes may be made and equivalents may be substituted for elements thereof without departing from the scope of the disclosure. In addition, many modifications may be made to adapt a particular situation or material to the teachings of the disclosure without departing from the scope thereof.
This is a continuation application of U.S. patent application Ser. No. 12/958,897 filed Dec. 2, 2010, which is a continuation application of U.S. patent application Ser. No. 11/983,264, filed Nov. 8, 2007, which claims the benefit of priority from U.S. Provisional patent application Ser. No. 60/857,694, filed on 8 Nov. 2006. Each of the above-noted applications is incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
1401358 | Peterkin | Dec 1921 | A |
2330257 | Bailey | Sep 1943 | A |
2391343 | Popper | Dec 1945 | A |
2412861 | George et al. | Dec 1946 | A |
2425004 | Rabell | Aug 1947 | A |
2433675 | Parish | Dec 1947 | A |
2455925 | Ganz | Dec 1948 | A |
2495420 | Popper | Jan 1950 | A |
2499414 | Rabell | Mar 1950 | A |
2761449 | Bletzinger | Sep 1956 | A |
3051177 | Wilson | Aug 1962 | A |
3079921 | Brecht et al. | Mar 1963 | A |
3320956 | Steiger | May 1967 | A |
3340874 | Burgeni | Sep 1967 | A |
3371666 | Lewing | Mar 1968 | A |
3397695 | Voss | Aug 1968 | A |
3409011 | Mittag | Nov 1968 | A |
3465390 | Mooney | Sep 1969 | A |
3572341 | Glassman | Mar 1971 | A |
3606643 | Mooney | Sep 1971 | A |
3610243 | Jones, Sr. | Oct 1971 | A |
3618605 | Glassman | Nov 1971 | A |
3628534 | Donohue | Dec 1971 | A |
3643661 | Crockford | Feb 1972 | A |
3674026 | Werner et al. | Jul 1972 | A |
3683912 | Olsen et al. | Aug 1972 | A |
3695270 | Dostal | Oct 1972 | A |
3699962 | Hanke | Oct 1972 | A |
3699965 | Dostal | Oct 1972 | A |
3712305 | Wennerblom et al. | Jan 1973 | A |
3731687 | Glassman | May 1973 | A |
RE27677 | Glassman | Jun 1973 | E |
3738364 | Brien et al. | Jun 1973 | A |
3749094 | Duncan | Jul 1973 | A |
3805786 | Bernardin et al. | Apr 1974 | A |
3811445 | Dostal | May 1974 | A |
3834389 | Dulle | Sep 1974 | A |
3854481 | Messing | Dec 1974 | A |
3981305 | Ring | Sep 1976 | A |
4200101 | Glassman | Apr 1980 | A |
4212301 | Johnson | Jul 1980 | A |
4274412 | Austin | Jun 1981 | A |
4318407 | Woon | Mar 1982 | A |
4326527 | Wollangk | Apr 1982 | A |
4335720 | Glassman | Jun 1982 | A |
4335721 | Mathews | Jun 1982 | A |
4373529 | Lilaonitkul et al. | Feb 1983 | A |
4374522 | Olevsky | Feb 1983 | A |
4543098 | Wolfe | Sep 1985 | A |
4627849 | Walton | Dec 1986 | A |
4787895 | Stokes et al. | Nov 1988 | A |
4835042 | Dohzono | May 1989 | A |
4836587 | Hinzmann | Jun 1989 | A |
4857044 | Lennon | Aug 1989 | A |
4973302 | Armour et al. | Nov 1990 | A |
5004467 | Hinzmann et al. | Apr 1991 | A |
5006116 | Alikhan et al. | Apr 1991 | A |
5047024 | Glassman | Sep 1991 | A |
5112348 | Glassman | May 1992 | A |
5149332 | Walton | Sep 1992 | A |
5153971 | Van Iten | Oct 1992 | A |
5314743 | Meirowitz et al. | May 1994 | A |
5364383 | Hayes et al. | Nov 1994 | A |
5389067 | Rejai | Feb 1995 | A |
5443776 | Bartholomew et al. | Aug 1995 | A |
5471820 | Oppe et al. | Dec 1995 | A |
5634248 | McNelis et al. | Jun 1997 | A |
5659934 | Jessup et al. | Aug 1997 | A |
5681894 | Williams et al. | Oct 1997 | A |
5755906 | Achter et al. | May 1998 | A |
5788910 | McNelis et al. | Aug 1998 | A |
5795346 | Achter et al. | Aug 1998 | A |
5804653 | Weng | Sep 1998 | A |
5807372 | Balzar | Sep 1998 | A |
5827256 | Balzar | Oct 1998 | A |
5873971 | Balzar | Feb 1999 | A |
5891081 | McNelis et al. | Apr 1999 | A |
5891123 | Balzar | Apr 1999 | A |
5931803 | Jackson | Aug 1999 | A |
5986000 | Williams et al. | Nov 1999 | A |
6003216 | Hull, Jr. | Dec 1999 | A |
6019744 | Altdorf et al. | Feb 2000 | A |
6039716 | Jessup et al. | Mar 2000 | A |
6039828 | Achter et al. | Mar 2000 | A |
6045526 | Jackson | Apr 2000 | A |
6142984 | Brown et al. | Nov 2000 | A |
6177608 | Weinstrauch | Jan 2001 | B1 |
6179802 | Jackson | Jan 2001 | B1 |
6183436 | Korteweg et al. | Feb 2001 | B1 |
6186994 | Bowles et al. | Feb 2001 | B1 |
6186995 | Tharpe, Jr. | Feb 2001 | B1 |
6248274 | Williams | Jun 2001 | B1 |
6283952 | Child | Sep 2001 | B1 |
6315763 | Albright et al. | Nov 2001 | B1 |
6333108 | Wilkes et al. | Dec 2001 | B1 |
6353146 | Williams | Mar 2002 | B1 |
6419777 | Achter et al. | Jul 2002 | B1 |
6478726 | Zunker | Nov 2002 | B1 |
6506958 | Williams | Jan 2003 | B2 |
6511452 | Rejai et al. | Jan 2003 | B1 |
6558370 | Moser | May 2003 | B2 |
6585300 | Rajala et al. | Jul 2003 | B1 |
6595974 | Pauley et al. | Jul 2003 | B1 |
6596919 | Williams | Jul 2003 | B2 |
6603054 | Chen et al. | Aug 2003 | B2 |
6635205 | Williams et al. | Oct 2003 | B2 |
6635800 | Jackson et al. | Oct 2003 | B2 |
6682513 | Agyapong et al. | Jan 2004 | B2 |
6702797 | Williams | Mar 2004 | B2 |
6719743 | Wada | Apr 2004 | B1 |
6740070 | Agyapong et al. | May 2004 | B2 |
D492033 | Jarmon et al. | Jun 2004 | S |
6746418 | Pauley et al. | Jun 2004 | B1 |
6814722 | Jackson et al. | Nov 2004 | B2 |
6830554 | Jackson et al. | Dec 2004 | B2 |
6886443 | Rejai | May 2005 | B2 |
6887226 | Cassoni et al. | May 2005 | B2 |
6890324 | Jackson et al. | May 2005 | B1 |
6923789 | LeMay et al. | Aug 2005 | B2 |
6932805 | Domeier et al. | Aug 2005 | B2 |
6953456 | Fuchs et al. | Oct 2005 | B2 |
7044928 | LeMay et al. | May 2006 | B2 |
7160279 | Pauley et al. | Jan 2007 | B2 |
7226436 | Gorham et al. | Jun 2007 | B2 |
7244497 | Hartmann et al. | Jul 2007 | B2 |
7250129 | Williams et al. | Jul 2007 | B2 |
7335194 | Wada | Feb 2008 | B2 |
7387622 | Pauley et al. | Jun 2008 | B1 |
D572362 | Edgett et al. | Jul 2008 | S |
7416997 | Kim et al. | Aug 2008 | B2 |
D579113 | Edgett et al. | Oct 2008 | S |
7563401 | Pham et al. | Jul 2009 | B2 |
7579078 | Hartmann et al. | Aug 2009 | B2 |
D612940 | Edgett et al. | Mar 2010 | S |
7678095 | Jackson et al. | Mar 2010 | B2 |
7704242 | LeMay et al. | Apr 2010 | B2 |
7727208 | Lemay et al. | Jun 2010 | B2 |
7727210 | LeMay et al. | Jun 2010 | B2 |
7745686 | Mauro et al. | Jun 2010 | B2 |
7780892 | Miller et al. | Aug 2010 | B2 |
7798986 | Melvin et al. | Sep 2010 | B2 |
7799966 | Williams et al. | Sep 2010 | B2 |
7815594 | Dougherty, Jr. et al. | Oct 2010 | B2 |
D626650 | Edgett et al. | Nov 2010 | S |
7862533 | LeMay et al. | Jan 2011 | B2 |
7867209 | Jorgensen et al. | Jan 2011 | B2 |
7887525 | Gorham et al. | Feb 2011 | B2 |
8070710 | Dougherty, Jr. | Dec 2011 | B2 |
8093446 | Knuth et al. | Jan 2012 | B2 |
8166834 | Dougherty, Jr. et al. | May 2012 | B2 |
8197434 | LeMay et al. | Jun 2012 | B2 |
8198504 | Glaug et al. | Jun 2012 | B2 |
8221375 | LeMay et al. | Jul 2012 | B2 |
8323256 | Edgett et al. | Dec 2012 | B2 |
8372027 | LeMay et al. | Feb 2013 | B2 |
8444590 | LeMay et al. | May 2013 | B2 |
8556845 | Lemay et al. | Oct 2013 | B2 |
8571883 | Dougherty, Jr. et al. | Oct 2013 | B2 |
8585668 | Pauley et al. | Nov 2013 | B2 |
8696957 | Dougherty, Jr. et al. | Apr 2014 | B2 |
8735647 | Schoelling | May 2014 | B2 |
8827974 | Schmidt-Forst | Sep 2014 | B2 |
8961449 | Jorgensen et al. | Feb 2015 | B2 |
9107775 | Edgett et al. | Aug 2015 | B2 |
9125771 | Schoelling | Sep 2015 | B2 |
9173778 | Schoelling | Nov 2015 | B2 |
9192522 | Edgett et al. | Nov 2015 | B2 |
20020107494 | Williams | Aug 2002 | A1 |
20020120243 | Kraemer et al. | Aug 2002 | A1 |
20020128620 | Jackson et al. | Sep 2002 | A1 |
20020156442 | Jackson et al. | Oct 2002 | A1 |
20030131456 | Rajala et al. | Jul 2003 | A1 |
20030149416 | Cole et al. | Aug 2003 | A1 |
20030158533 | Agyapong et al. | Aug 2003 | A1 |
20030172504 | Sageser | Sep 2003 | A1 |
20030208180 | Fuchs et al. | Nov 2003 | A1 |
20030225389 | Cassoni et al. | Dec 2003 | A1 |
20030236499 | Fedyk et al. | Dec 2003 | A1 |
20040019317 | Takagi et al. | Jan 2004 | A1 |
20040126555 | Hartmann et al. | Jul 2004 | A1 |
20040019313 | Wada | Sep 2004 | A1 |
20040193131 | Wada | Sep 2004 | A1 |
20050059944 | Jackson et al. | Mar 2005 | A1 |
20050096619 | Costa | May 2005 | A1 |
20070026228 | Hartmann et al. | Feb 2007 | A1 |
20070234532 | Gilbert | Oct 2007 | A1 |
20070260211 | Schmidt-Forst | Nov 2007 | A1 |
20080065041 | Stan et al. | Mar 2008 | A1 |
20080097366 | Matthews | Apr 2008 | A1 |
20080110005 | Gilbert et al. | May 2008 | A1 |
20080119811 | Gilbert et al. | May 2008 | A1 |
20080281514 | Dougherty, Jr. et al. | May 2008 | A1 |
20080221502 | Binner et al. | Sep 2008 | A1 |
20080262464 | Hasse et al. | Oct 2008 | A1 |
20080287902 | Edgett et al. | Nov 2008 | A1 |
20090036859 | Dougherty, Jr. et al. | Feb 2009 | A1 |
20090082712 | Hasse et al. | Mar 2009 | A1 |
20090234268 | Jorgensen et al. | Mar 2009 | A1 |
20090156979 | Andersch | Jun 2009 | A1 |
20090227975 | Dougherty, Jr. et al. | Sep 2009 | A1 |
20090247981 | Glaug et al. | Oct 2009 | A1 |
20090281474 | Dougherty, Jr. et al. | Nov 2009 | A1 |
20100036309 | Jorgensen, Jr. et al. | Feb 2010 | A1 |
20100056981 | Karapasha et al. | Mar 2010 | A1 |
20100120707 | Dougherty, Jr. et al. | May 2010 | A1 |
20100160886 | Jackson et al. | Jun 2010 | A1 |
20100198133 | Dougherty, Jr. et al. | Aug 2010 | A1 |
20110224637 | Edgett et al. | Sep 2011 | A1 |
20120061867 | Dougherty, Jr. et al. | Mar 2012 | A1 |
20130018347 | Edgett et al. | Jan 2013 | A1 |
20140265026 | Schoelling | Sep 2014 | A1 |
20140276523 | Schoelling | Sep 2014 | A1 |
20150105711 | LeMay et al. | Apr 2015 | A1 |
20150320608 | Edgett et al. | Jul 2015 | A1 |
Number | Date | Country |
---|---|---|
768046 | Nov 1971 | BE |
2127144 | Oct 1995 | CA |
2441647 | May 1996 | CA |
2180789 | Jan 1997 | CA |
2312666 | Jan 2001 | CA |
108982 | Aug 2006 | CA |
115880 | Aug 2008 | CA |
2207687 | Jun 1974 | FR |
2505176 | Nov 1982 | FR |
1108197 | Apr 1968 | GB |
2073592 | Oct 1981 | GB |
9306074 | May 1993 | GB |
8904080 | Jun 1990 | IE |
109027 | Jun 1994 | IL |
SHO44004240 | Feb 1944 | JP |
62-8754 | Jan 1987 | JP |
63-212358 | Sep 1988 | JP |
H05-68695 | Mar 1993 | JP |
2001-008964 | Jan 2001 | JP |
2005-526584 | Sep 2005 | JP |
SHO62-027952 | Sep 2005 | JP |
WO9933428 | Jul 1999 | WO |
WO0006071 | Feb 2000 | WO |
WO0124729 | Apr 2001 | WO |
WO0166055 | Sep 2001 | WO |
WO02058587 | Aug 2002 | WO |
WO2003101362 | Nov 2003 | WO |
WO2005041883 | May 2005 | WO |
WO2005112856 | Dec 2005 | WO |
WO2005112862 | Dec 2005 | WO |
WO2006016933 | Feb 2006 | WO |
WO2007078413 | Feb 2007 | WO |
WO 2007078413 | Jul 2007 | WO |
WO2008056339 | May 2008 | WO |
WO200809331 | Aug 2008 | WO |
WO2008144624 | Nov 2008 | WO |
8803191 | Nov 1988 | ZA |
9706745 | Feb 1998 | ZA |
Entry |
---|
Playtex Beyond tampon (2005). |
Playtex Gentle Glide tampon ( 2005). |
Examination Report for corresponding GB Application No. GB1117582.5, dated Mar. 27, 2013, pp. 1-2. |
English Translation of Decision of Rejection against Japanese Patent Application No. 2012-506079; dated Jan. 7, 2013; pp. 1-4. |
International Search Report for PCT/US2010/030351 dated Jun. 3, 2010. |
PCT International Search Report, International Application No. PCT/US2008/064074, International Filing Date May 19, 2008, dated Jul. 21, 2008. |
First Office Action Against JP Application No. 2010-508629, dated Dec. 20, 2011. |
International Search Report dated Jun. 2, 2008, for International application No. PCT/*S07/13749. |
Written Opinion dated Jun. 2, 2008, for International application No. PCT/US07/13749. |
English Translation of Decision of Rejection against Japanese Patent Application No. 2010-508629; dated Dec. 27, 2012; pp. 1-3. |
First Office Action dated Feb. 13, 2012 from Japanese Application No. 2009-536296. |
Korean Office Action dated Dec. 16, 2011 from Korean Application No. 10-2009-7011433. |
First Office Action dated Feb. 13, 2012, from Japanese Application No. 2009-536296. |
Supplemental European Search Report dated Aug. 5, 2011, from European Application No. 07839986.2. |
Office Action dated Apr. 11, 2011 for corresponding Korean Patent Application No. 10-2009-7011433 with English summary of Office Action. |
Examination Report for Canadian Patent Application No. 2669469 dated Dec. 1, 2010. |
2005 Gentle Glide Plastic Tampons. |
Number | Date | Country | |
---|---|---|---|
20160100993 A1 | Apr 2016 | US |
Number | Date | Country | |
---|---|---|---|
60857694 | Nov 2006 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12958897 | Dec 2010 | US |
Child | 14972442 | US | |
Parent | 11983264 | Nov 2007 | US |
Child | 12958897 | US |